Ö. Açıkgöz, Sabin Göktaş Aydın, A. Bilici, Yasin Kutlu, Harun Muğlu, E. Karci, J. Hamdard, E. Mammadov, Ö. Ölmez, Özcan Yıldız
{"title":"cdk4 /6抑制剂联合内分泌治疗激素受体阳性、人表皮生长因子受体-2阴性转移性乳腺癌患者的疗效和安全性","authors":"Ö. Açıkgöz, Sabin Göktaş Aydın, A. Bilici, Yasin Kutlu, Harun Muğlu, E. Karci, J. Hamdard, E. Mammadov, Ö. Ölmez, Özcan Yıldız","doi":"10.5505/aot.2023.00187","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":435847,"journal":{"name":"Acta Oncologica Turcica","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Efficacy And Safety of CDK 4/6 Inhibitors Plus Endocrine Therapy With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2- Negative Metastatic Breast Cancer Patients\",\"authors\":\"Ö. Açıkgöz, Sabin Göktaş Aydın, A. Bilici, Yasin Kutlu, Harun Muğlu, E. Karci, J. Hamdard, E. Mammadov, Ö. Ölmez, Özcan Yıldız\",\"doi\":\"10.5505/aot.2023.00187\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":435847,\"journal\":{\"name\":\"Acta Oncologica Turcica\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Oncologica Turcica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5505/aot.2023.00187\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oncologica Turcica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/aot.2023.00187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Efficacy And Safety of CDK 4/6 Inhibitors Plus Endocrine Therapy With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2- Negative Metastatic Breast Cancer Patients